🆕 One-page research summary for families: ASO therapy!
ASO therapy has shown promising results in mouse models of Lafora disease, preventing Lafora Body formation and mitigating neuroinflammation.
TITLE: Antisense oligonucleotide (ASO) therapy targeting Gys1 gene
AUTHORS: Saija Ahonen, Silvia Nitschke, Tamar R. Grossman, Holly Kordasiewicz, Peixiang Wang, Xiaochu Zhao, Dikran R. Guisso, Sahba Kasiri, Felix Nitschke and Berge A. Minassian
RESEARCH SIMPLIFIED BY: Maysoon Hussain
🔗 Follow the link in our bio to read it!
You can also find the original publication linked on our website!
#ChelseasHopeLaforaCure #LaforaDisease #LaforaDiseaseResearch #ChelseasHope #RareDisease #FightLafora #ASOTherapy #ION283 #Research #RareDiseaseResearch #CureLaforaDisease #NotAStepBack
Media Description: The image has a photo of two hands holding a tablet with a PDF on it in front of a torso in a blue sweater, though the title is the only legible part of the PDF: Antisense oligonucleotide therapy targeting Gys1 gene. Text says 'Antisense oligonucleotide therapy targeting Gys1 gene ONE PAGE RESEARCH SUMMARY FOR FAMILIES.' There's a green graphic in the top left that says NEW! and the horizontal Chelsea's Hope Lafora Children Research Fund logo is in the bottom right-hand corner.